Xeris Pharmaceuticals, Inc.


Date of Award

02.19.2014

Program

Type 1 Diabetes, Improve Outcomes

Amount

$421,600

Term of Grant

25 months

Project Title

Rapid Acting Insulin and Insulin-Pramlintide Formulations for Treatment of Diabetes